Comparison of six pharmacologic regimens for hypercholesterolemia
- 1 April 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (8) , 812-816
- https://doi.org/10.1016/0002-9149(87)91097-6
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- The effects of mevinolin and neomycin alone and in combination on plasma lipid and lipoprotein concentrations in type II hyperlipoproteinemiaAtherosclerosis, 1986
- Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaThe American Journal of Cardiology, 1986
- Effects of combination cholestyramine-neomycin treatment on plasma lipoprotein concentrations in type II hyperlipoproteinemiaThe American Journal of Cardiology, 1985
- Lowering Blood Cholesterol to Prevent Heart DiseaseJAMA, 1985
- Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin.Circulation, 1984
- Neomycin and plasma lipoproteins in type II hyperlipoproteinemiaClinical Pharmacology & Therapeutics, 1984
- Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in Type IIb hyperlipoproteinemiaMetabolism, 1981
- Effect of colestipol and clofibrate on plasma lipid and lipoproteins in Type IIa hyperlipoproteinemiaMetabolism, 1981
- COLESTIPOL PLUS NICOTINIC ACID IN TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIAThe Lancet, 1981
- Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug RegimenNew England Journal of Medicine, 1981